Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 CAD | +2.15% | +2.15% | +20.25% |
08/04 | HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA | CI |
14/03 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- Analyst Reco.